People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

16 In the future, CRISPR diagnostics have the potential to transform the field of personalized medicine. By enabling the rapid and precise identification of genetic predispositions, these tools ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has earned a consensus recommendation of “Hold” from the nineteen ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.